Immunohistochemical analysis of SSTR-2 expression in pulmonary neuroendocrine tumors was reviewed retrospectively in a series of 218 “clinically aggressive cases” including 60 LCNEC. This evidence concerns the gene SSTR2 and lung neuroendocrine neoplasm.